AFGV.Y Stock Overview
Develops, produces, and distributes various analog and digital imaging systems worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Agfa-Gevaert NV Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.78 |
| 52 Week High | €3.10 |
| 52 Week Low | €1.78 |
| Beta | 0.69 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | -78.11% |
| Change since IPO | -69.45% |
Recent News & Updates
Recent updates
Shareholder Returns
| AFGV.Y | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | 2.2% |
| 1Y | n/a | 8.2% | 31.6% |
Return vs Industry: Insufficient data to determine how AFGV.Y performed against the US Healthcare Services industry.
Return vs Market: Insufficient data to determine how AFGV.Y performed against the US Market.
Price Volatility
| AFGV.Y volatility | |
|---|---|
| AFGV.Y Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 9.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AFGV.Y's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine AFGV.Y's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1867 | 4,819 | Pascal Juery | www.agfa.com |
Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems worldwide. It operates through four segments: HealthCare IT, Digital Print & Chemicals, Radiology Solutions, and CONOPS. The company’s CONOPS segment engages in supply of film and chemicals, as well support services.
Agfa-Gevaert NV Fundamentals Summary
| AFGV.Y fundamental statistics | |
|---|---|
| Market cap | US$108.02m |
| Earnings (TTM) | -US$33.32m |
| Revenue (TTM) | US$1.17b |
0.1x
P/S Ratio-3.2x
P/E RatioIs AFGV.Y overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AFGV.Y income statement (TTM) | |
|---|---|
| Revenue | €1.13b |
| Cost of Revenue | €774.00m |
| Gross Profit | €352.00m |
| Other Expenses | €384.00m |
| Earnings | -€32.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.21 |
| Gross Margin | 31.26% |
| Net Profit Margin | -2.84% |
| Debt/Equity Ratio | 0% |
How did AFGV.Y perform over the long term?
See historical performance and comparison